Rani Therapeutics Holdings (RANI) EBT (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly EBT came in at -$10.4 million in Q1 2026, up 18.72% year-on-year from -$8.7 million in Q1 2025, and down 20.02% quarter-over-quarter from -$8.6 million in Q4 2025.
Rani Therapeutics Holdings (RANI) EBT (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' EBT history runs 7 years deep, the most recent figure standing at -$10.4 million for Q1 2026.
- On a quarterly basis, EBT rose 18.72% year-over-year to -$10.4 million in Q1 2026; TTM through Mar 2026 was -$42.2 million, a 29.57% increase from a year earlier, with the FY2025 full-year figure at -$116.5 million, down 105.96% from the prior year.
- EBT declined to -$10.4 million in Q1 2026 per RANI's latest filing, from -$8.6 million in the prior quarter.
- Across five years, EBT topped out at -$8.6 million in Q4 2025 and bottomed at -$18.7 million in Q2 2023.
- The 5-year median for EBT is -$14.8 million (2024), against an average of -$14.6 million.
- Across the five-year window, EBT plunged 188.33% in 2022 and surged 45.13% in 2025, its largest moves.
- Year by year, EBT stood at -$17.4 million in 2022, then grew by 19.15% to -$14.1 million in 2023, then retreated by 11.86% to -$15.7 million in 2024, then surged by 45.13% to -$8.6 million in 2025, then decreased by 20.02% to -$10.4 million in 2026.
- Per Business Quant, the three latest RANI EBT figures stand at -$10.4 million (Q1 2026), -$8.6 million (Q4 2025), and -$12.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | -10.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.35 Mn |
| Dec 31, 2025 | -8.63 Mn |
| Sep 30, 2025 | -11.96 Mn |
| Jun 30, 2025 | -11.30 Mn |
| Mar 31, 2025 | -12.74 Mn |
| Dec 31, 2024 | -15.72 Mn |
| Sep 30, 2024 | -18.05 Mn |
| Jun 30, 2024 | -13.46 Mn |
| Mar 31, 2024 | -14.78 Mn |
| Dec 31, 2023 | -14.06 Mn |
| Sep 30, 2023 | -18.33 Mn |
| Jun 30, 2023 | -18.66 Mn |
| Mar 31, 2023 | -16.83 Mn |
| Dec 31, 2022 | -17.38 Mn |
| Sep 30, 2022 | -16.32 Mn |
| Jun 30, 2022 | -15.81 Mn |
| Mar 31, 2022 | -13.77 Mn |
| Dec 31, 2021 | -13.35 Mn |
| Sep 30, 2021 | -28.66 Mn |
| Jun 30, 2021 | -5.48 Mn |